Omnicell, Inc. (OMCL)

Healthcare · Health Information Services · NASDAQ

Omnicell, Inc. (OMCL) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $1.67B, a trailing price-to-earnings ratio of 15.3 and a free-cash-flow yield of 4.1%. Over the most recent reported fiscal year, revenue grew 6.5% and free cash flow per share fell 48.7%.

Market cap	$1.67B
Trailing P/E	15.3
FCF yield	4.1%
Revenue growth (YoY)	+6.5%
EPS growth (YoY)	-4.7%
FCF/share growth (YoY)	-48.7%
Exchange	NASDAQ
Sector	Healthcare
Industry	Health Information Services

Explore live OMCL data on Nama Insights →

Recent Congressional trades

Omnicell, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Sara Jacobs	House	Sell	$50,001 - $100,000	May 11, 2021
Thomas R Tillis	Senate	Sell	$1,001 - $15,000	—